Pharmaseed



Paving The Way For Clinical Success Through Collaboration


Email






Value Proposition

We are committed to provide high quality & cost-effective preclinical services with faster turnaround times

Experience & Expertise

Comprehensive services including study design and advanced data analysis.

Global Network of Partners

Partnerships with certified labs across EU and US, providing access to specialized expertise and cutting-edge resources.

Project Management

dedicated Study Director and Laboratory Technician assigned to your project.

Transparent Communication

Routine bi-weekly or monthly updates ensure clients are informed every step of the way.

OUR SERVICES

Animal Models

Established & customized in vivo studies across a wide range of therapeutic areas, including cardiovascular, oncology, neurology, metabolic disorders, and more. Leveraging our extensive expertise in translational research to accelerate your pipeline.

In Vitro & Ex Vivo Assays

State-of-the-art cell-based assays, immunoassays, and high-throughput screening capabilities to comprehensively evaluate your compounds' safety and efficacy. Our multidisciplinary expertise spans regenerative medicine, microbiome research, and beyond.

Consulting & Regulatory and Strategic Guidance

Strategic guidance to navigate the clinical development journey, from study design and feasibility assessments to seamless operational execution during early-stage trials. We partner with you to transform innovative ideas into sustainable health solutions.

Comprehensive In Vivo Research Platforms

GLP Toxicity Studies


Neurological Disorders


Oncology


Inflammation & Immunology


Metabolic Disorders


Vascular & Cardiovascular


Infectious Disease & Microbiome


Ophthalmology


Longevity


In Vivo GLP Studies

Accelerating Drug Development with Regulatory-Compliant Preclinical Testing

Regulatory Excellence

Our GLP-compliant in vivo studies adhere to FDA, EMA, and OECD guidelines, ensuring the highest standards of quality, safety, and documentation for regulatory approval.

Comprehensive Toxicology & Safety Testing

✔️ Single & repeat-dose toxicity
✔️ Carcinogenicity & genotoxicity
✔️ Reproductive toxicology
✔️ Safety pharmacology

Expert Data & Regulatory Support

🔹 Pathology & toxicokinetics evaluations
🔹 Integrated data interpretation for regulatory submissions
🔹 Comprehensive IND-supporting reports

Neurological Disease Models

1

Degenerative Disease

Alzheimer’s, Parkinson’s, ALS, Spinal Cord Injury

Comprehensive in vivo models to study disease progression and therapeutic interventions.

2

Diabetic Neuropathy, Chemotherapy-Induced Peripheral Neuropathy

Robust models for evaluating novel pain management and neuroprotective therapies.

3

Stroke & Vascular Dementia

Middle Cerebral Artery Occlusion (MCAO), Photothrombotic Stroke

Clinically relevant models for assessing neurovascular dysfunction and recovery strategies.

4

Traumatic Nerve Injury

Precision models to evaluate nerve regeneration and neurorehabilitation approaches.

Cancer Models

Syngeneic Models

Genetically engineered mice with specific cancer mutations
Ideal for studying tumor-immune system interactions and immunotherapies

Xenograft Models

Human tumor cells implanted into immunodeficient mice
Reliable platform for evaluating anti-cancer drug efficacy

Patient-Derived Xenograft (PDX) Models

Directly derived from patient tumor tissue
Highly predictive models for personalized medicine & translational research

Revolutionize Cancer Research

Advanced 3D Models

Cutting-edge tumoroid and spheroid models derived from minimal samples, covering diverse cancer types.

Tumor-On-a-Chip Platform

low-based culture systems that better replicate the human body compared to traditional static models.

Versatile Testing

Evaluate oncology drugs, biologics, radiotherapy, and emerging therapies with high precision.

With 95% of cancer drugs failing in clinical trials, our 3D cell culture models provide more reliable, predictive insights by preserving the tumor microenvironment.

Inflammation & Immunological Models

1

Inflammatory Bowel Disease

Clinically relevant models for Crohn’s disease & ulcerative colitis
Evaluating novel anti-inflammatory & immunomodulatory therapies

2

Allergies

Food allergies, allergic asthma, and rhinitis
Preclinical testing for desensitization strategies & targeted treatments

3

Autoimmune Diseases

Rheumatoid arthritis, systemic lupus erythematosus (SLE), multiple sclerosis
Investigating disease mechanisms & immune-targeted therapies



Metabolic Disorder Models

1

Diabetes

Type 1 & Type 2 diabetes models for evaluating novel insulin therapies and glucose regulation strategies.

2

Obesity

Induced by high-fat diets & genetic modifications, mimicking human metabolic dysfunction.

3

Fatty Liver Disease (NAFLD)

Clinically relevant models for non-alcoholic fatty liver disease, supporting drug development and lifestyle intervention studies.

Vascular Disease Models

Hind Limb Ischemia (HLI)

Rodent models for vascular regeneration and perfusion recovery, aiding in therapeutic angiogenesis research.

Atherosclerosis

Genetically modified mouse models to study plaque formation, lipid metabolism, and therapeutic interventions.

Hypertension

Models developed through genetic and dietary manipulations, mimicking human hypertensive conditions.

Heart Failure

Preclinical models induced by pressure overload and myocardial infarction, supporting drug discovery and regenerative therapies.

Infectious Disease & Microbiome Models

1

Bacterial Infections

Clinically relevant models for studying pneumonia, sepsis, and antimicrobial therapies.

2

Viral Infections

reclinical models for investigating HIV, hepatitis, and antiviral drug efficacy..

3

Parasitic Infections

Malaria and other parasitic diseases, supporting the development of novel therapeutics.

4

Microbiome & Host Interaction

Exploring the role of the microbiome in health and disease, with models for gut, skin, and systemic microbiome studies.




Ophthalmology Models

Glaucoma

Models induced by elevated intraocular pressure, mimicking disease progression and neurodegeneration.

Age-Related Macular Degeneration (AMD)

Preclinical models for both dry and wet AMD, supporting drug discovery and intervention strategies.

Diabetic Retinopathy

Models replicating proliferative and non-proliferative diabetic retinopathy, enabling evaluation of novel therapies.


Longevity Models

Genetically Engineered Models

Genetically modified mice with targeted mutations in longevity-related genes to study lifespan extension and aging mechanisms.

Dietary Restriction Models

Caloric restriction and dietary interventions to explore the impact of metabolism on aging and age-related diseases.

🔹 Cutting-edge models for aging and longevity research
🔹 Supporting the development of novel anti-aging therapies

Thank You! 🙌


We are dedicated to delivering high-quality, cost-effective preclinical services with efficient turnaround times to accelerate your research and development.

Partner with us for innovative, reliable preclinical solutions!